Recursion Pharmaceuticals, a Salt Lake City-based biotechnology company using machine learning artificial intelligence to develop new drugs, raised $121 million in its latest funding round.
Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage ...
This article checks, using both real and simulated data, the effectiveness of modern adaptive techniques to track the parameters of time-varying dynamic models. The real case studies concern a bone ...
In early May, Salt Lake City-based Recursion Pharmaceuticals announced that it was releasing an open-source, 300-gigabyte dataset of genetically altered cell images to accelerate the use of artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback